ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TRDA Entrada Therapeutics Inc

13.16
0.00 (0.00%)
Pre Market
Last Updated: 03:16:16
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Entrada Therapeutics Inc TRDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 13.16 03:16:16
Open Price Low Price High Price Close Price Previous Close
13.16
more quote information »

Recent News

Date Time Source Heading
3/13/202406:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
3/08/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:22EDGAR2Form 144 - Report of proposed sale of securities
3/06/202415:22EDGAR2Form 144 - Report of proposed sale of securities
3/05/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/07/202406:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
1/03/202406:16EDGAR2Form 8-K - Current report
1/03/202406:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
12/26/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202315:26EDGAR2Form 144 - Report of proposed sale of securities
12/06/202306:00EDGAR2Form 8-K - Current report
11/22/202310:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
11/22/202306:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
11/22/202306:35EDGAR2Form 8-K - Current report
11/22/202306:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
11/07/202306:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:08EDGAR2Form 8-K - Current report
11/07/202306:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
11/01/202306:01EDGAR2Form 8-K - Current report
10/12/202306:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
9/29/202315:39EDGAR2Form 8-K - Current report
9/29/202315:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
9/21/202306:09EDGAR2Form 8-K - Current report
9/21/202306:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
9/07/202306:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
9/06/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202315:09EDGAR2Form 144 - Report of proposed sale of securities
9/06/202315:09EDGAR2Form 144 - Report of proposed sale of securities
9/06/202315:08EDGAR2Form 144 - Report of proposed sale of securities
9/05/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202315:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/29/202306:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
8/10/202306:09EDGAR2Form 8-K - Current report
8/10/202306:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
8/08/202306:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
8/08/202306:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
8/08/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202306:07EDGAR2Form 8-K - Current report
8/08/202306:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
8/04/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202315:10EDGAR2Form 144 - Report of proposed sale of securities
8/01/202306:08EDGAR2Form 8-K - Current report
8/01/202306:00GLOBEEntrada Therapeutics Receives Authorization in the United..
7/12/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock